Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzdiimidazole ligand's rescue of Parkinson's-associated cell toxicity
A. K. Hatstat, B. Quan, M. Bailey, M. C. Fitzgerald, M. C. Reinhart, D. G. McCafferty
This paper identifies Rab1a as a target of the compound NAB2, which rescues Parkinson's-associated cell toxicity by restoring ER-to-Golgi trafficking.
bioRxiv · May 5, 2021Biochemistry